Oziminski Wojciech Piotr, Bycul Agata
Department of Organic and Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Street, 02-097 Warsaw, Poland.
J Org Chem. 2023 Oct 6;88(19):14048-14064. doi: 10.1021/acs.joc.3c01580. Epub 2023 Sep 27.
The mechanism of action of molnupiravir, a novel antiviral drug, was analyzed from the point of view of its tautomerism by means of quantum-mechanical calculations. It was established that although the uracil-like tautomer M (3 kcal/mol in the water environment) is the most thermodynamically stable, in fact, it is the cytosine-like tautomer M that plays the main role. There are several reasons, as follows: (1) A large part of M exists as a more stable but inactive form M-m that is unable to pair with adenine. (2) The phosphorylated form of M is only 1 kcal/mol less stable than M in the water environment and thus is readily available for building into the RNA strand, where the M/M energy gap increases and the probability of M → M interconversion leading to C → U mutation is high. (3) The guanine-M complex has similar stability to guanine-cytosine, but the adenine-M complex has lower stability than adenine-uracil. Additionally, the guanine-M complex has a suboptimal distorted geometry that further facilitates the mutations. (4) The activation barrier for proton transfer leading to M-m interconversion into a cytosine-like tautomer is higher than for M, which makes the uracil-like form even less available. These facts confirm an intriguing experimental observation that molnupiravir competes mainly with cytosine and not uracil.
通过量子力学计算,从互变异构的角度分析了新型抗病毒药物莫努匹韦的作用机制。结果表明,尽管尿嘧啶样互变异构体M(在水环境中为3千卡/摩尔)在热力学上最稳定,但实际上起主要作用的是胞嘧啶样互变异构体M。原因如下:(1)M的很大一部分以更稳定但无活性的形式M-m存在,无法与腺嘌呤配对。(2)M的磷酸化形式在水环境中仅比M稳定1千卡/摩尔,因此很容易整合到RNA链中,在那里M/M的能量差距增大,M→M互变导致C→U突变的概率很高。(3)鸟嘌呤-M复合物与鸟嘌呤-胞嘧啶具有相似的稳定性,但腺嘌呤-M复合物的稳定性低于腺嘌呤-尿嘧啶。此外,鸟嘌呤-M复合物具有次优的扭曲几何结构,进一步促进了突变。(4)导致M-m互变形成胞嘧啶样互变异构体的质子转移活化能垒高于M,这使得尿嘧啶样形式更难出现。这些事实证实了一个有趣的实验观察结果,即莫努匹韦主要与胞嘧啶而非尿嘧啶竞争。